Clinical trial Recruiting at 1 site Interventional Ages 21 to 79

Optimizing blood flow to protect the brain after cardiac arrest

Official title: NEUROprotection Via optimizINg Cerebral Blood Flow afTer cArdiaC arresT (NEURO-INTACT) Study

Run by National University Hospital, Singapore · NCT05679739 · Data updated 2026-11-12

This study is testing a personalized blood pressure management plan to see if it can help protect the brains of people who have had a cardiac arrest.

Quick facts

Study typeInterventional
Ages21 Years to 79 Years
SexAll
Enrollment49 (estimated)
SponsorNational University Hospital, Singapore
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedAugust 29, 2023
Main results expectedAugust 2025
Study endsAugust 2026
Registry record updatedMay 16, 2025
Trial IDNCT05679739 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 to 79 who are comatose following a return of spontaneous circulation after cardiac arrest.

Probably not a fit

Patients aged 80 and older, pregnant individuals, or those with limitations on care may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This proof of concept study evaluates an individualized blood pressure management strategy aimed at enhancing cerebral blood flow in patients who have experienced out-of-hospital cardiac arrest. The approach involves using advanced monitoring techniques, including transcranial Doppler ultrasound and near-infrared spectroscopy, to tailor blood pressure targets for each patient. The effectiveness of this strategy will be assessed by measuring levels of neuron-specific enolase, a biomarker for brain injury, at baseline and 72 hours post-intervention. The study aims to recruit 49 patients to determine if this personalized approach can reduce brain injury compared to standard care.

Why it matters

Potential benefit: If successful, this study could lead to improved brain recovery and outcomes for patients who suffer cardiac arrest.

How similar studies have gone: While this approach is innovative, similar studies targeting cerebral perfusion have shown promise, but this specific strategy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. At least 21 years of age
2. Comatose defined as not being able to obey verbal commands and no verbal response to pain after sustained ROSC.

Exclusion Criteria:

1. ≥ 80 years old at time of enrolment
2. Pregnant patients
3. Limitations of care or life support therapy withdrawn within 24 hours of admission

Where it's running

  • National University Heart Centre, Singapore
    Singapore, Singapore
    Recruiting

Study contacts

  • Principal investigator: Shir Lynn Lim — National University Hospital, Singapore
  • Study coordinator: Shir Lynn Lim
  • Email: shir_lynn_lim@nuhs.edu.sg
  • Phone: 69082222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.